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Abstract
Articular cartilage defects, when repaired ineffectively, often lead to further deterioration of the tissue, secondary osteo-
arthritis and, ultimately, joint replacement. Unfortunately, current surgical procedures are unable to restore normal car-
tilage function. Tissue engineering of cartilage provides promising strategies for the regeneration of damaged articular
cartilage. As yet, there are still significant challenges that need to be overcome to match the long-term mechanical stability
and durability of native cartilage. Using electrospinning of different blends of biodegradable poly(3-hydroxybutyrate)/poly(3-
hydroxyoctanoate), we produced polymer scaffolds and optimised their structure, stiffness, degradation rates and biocom-
patibility. Scaffolds with a poly(3-hydroxybutyrate)/poly(3-hydroxyoctanoate) ratio of 1:0.25 exhibit randomly oriented
fibres that closely mimic the collagen fibrillar meshwork of native cartilage and match the stiffness of native articular
cartilage. Degradation of the scaffolds into products that could be easily removed from the body was indicated by changes
in fibre structure, loss of molecular weight and a decrease in scaffold stiffness after one and four months. Histological and
immunohistochemical analysis after three weeks of culture with human articular chondrocytes revealed a hyaline-like
cartilage matrix. The ability to fine tune the ultrastructure and mechanical properties using different blends of poly(3-
hydroxybutyrate)/poly(3-hydroxyoctanoate) allows to produce a cartilage repair kit for clinical use to reduce the risk of
developing secondary osteoarthritis. We further suggest the development of a toolbox with tailor-made scaffolds for the
repair of other tissues that require a ‘guiding’ structure to support the body’s self-healing process.
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Introduction
Articular cartilage (AC) is a load-bearing tissue that
acts as a shock absorber to protect the ends of the
long bones in synovial joints and provides an almost
frictionless gliding of the opposing bone surfaces, often
over a lifetime. During the course of daily activities
such as walking, stair climbing or squatting, the AC
in the knee and hip joints is regularly loaded up to
several times the body weight, which makes it suscep-
tible to injuries by impact or torsional loadings. Due to
the limited ability of AC to self-repair, AC is known as
a tissue that ‘once destroyed, is not repaired’.1 Hence,
eﬀective treatments are needed to prevent further
degeneration of the lesion into secondary osteoarthritis.
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Some ﬁrst-line clinical treatments are based on marrow
stimulation techniques, such as Pridie drilling, abrasion
and microfracture.2–4 Unfortunately, marrow stimula-
tion techniques produce predominantly ﬁbrocartilage
that largely consists of disorganised type I collagen
ﬁbrils, which are mechanically inferior and non-dur-
able.3,5,6 Another widely used technique, the autolo-
gous chondrocyte transplantation (ACT), often leads
to functionally weak ﬁbrocartilage.7–10
Hydrogels such as collagen,11,12 hyaluronan,13 chit-
osan14 and poly(ethylene glycol) (PEG)6,15 have been
tested in clinical studies. A few products have obtained
regulatory status.11,13–15 In addition, the liquid precur-
sors of chitosan14 and PEG6,15 were combined with the
microfracture technique to provide a three-dimensional
(3D) environment for the diﬀerentiation of bone
marrow stem cells into chondrocytes. However, hydro-
gels cannot withstand the joint loading forces and
deteriorate easily. The mismatch of mechanical proper-
ties between the hydrogel and the surrounding host
tissue induces shear stresses on the interfaces, which
prevents the ingrowth of new cartilage. When increas-
ing the polymer concentration to match the stiﬀness of
native cartilage, the result is a reduction of cell viabil-
ity.16 This unsatisfactory behaviour of hydrogels for
cartilage repair may be explained by comparing hydro-
gels with cartilage. AC exhibits two principle matrix
components, the proteoglycans and the collagen ﬁbril
meshwork, which are acting in concert and are
responsible for the tissue’s functional properties,
whereas a hydrogel is only a structural simple amorph-
ous material that cannot mimic the tissue complexity.
When cells anchor to the surrounding matrix, the
diﬀerences in cell–matrix interactions and the altered
stimuli of the cell surface receptors lead to changes in
the cell signalling pathways, protein synthesis and
altered tissue formation. The lack of integration of
the engineered cartilage, as well as the diﬀerences
in the structural and mechanical properties between
scaﬀolds and the surrounding native cartilage may
be the main reasons for the development of ﬁbrous
cartilage.
Another popular class of structural supports is
poly(a-hydroxy acids) polymers such as poly(glycolic
acid) and poly(lactic acid).17–19 Their copolymers,
poly(lactic-co-glycolic acid) (PLGA), are Food and
Drug Administration approved biomaterials that have
been employed as resorbable suture materials for sev-
eral decades. More recently, PLGA has also been
employed for repairing chondral and osteochondral
defects.20,21 To mimic the collagen ﬁbril meshwork of
AC, the polymers have been fabricated into meshworks
of electrospun ﬁbres.19,22 It was reported that the rapid
degradation of these co-polymers increased the acidity
in the microenvironment, which reduced cell viability
and cell migration into the scaﬀolds.23 The release of
acidic by-products leads to inﬂammations in the host
body, particularly in orthopaedic applications where
larger-sized implants are often required.24–26
A major hurdle in the engineering of cartilage is the
de-diﬀerentiation of chondrocytes when exposed to a
synthetic microenvironment,27 which often results in
the development of calciﬁed or ﬁbrous cartilage. The
dependence of cell fate on the microenvironment is
well-known in stem cell research. Stem cells diﬀerenti-
ate into the speciﬁc mature tissue cells when being
exposed to the microenvironment of their extracellular
matrix.28 The dominating role of the microenvironment
in directing tissue development has been most impres-
sively demonstrated in cancer research, where in a series
of experiments normal cells were turned into cancer
cells, and reversed back into normal cells by changing
the (micro-) environment.29–31 Inspired by those ﬁnd-
ings, we aim to develop a cartilage-speciﬁc extracellular
matrix to provide a microenvironment that mimics
native cartilage and that favours neo-cartilage growth.
Once new functional cartilage grows into the defect site,
the polymer ﬁbrils degrade into biocompatible small-
sized molecules and are transported as waste material
out of the body. To achieve these key requirements,
biodegradable polyhydroxyalkanoates (PHAs), which
exhibit a wide range of structural, physicochemical
and thermal properties, are employed in this research.
PHAs are a family of biopolyesters synthesised by a
wide variety of bacteria under the conditions of limiting
nutrients but excess carbon source. Figure 1 shows the
general structure of PHAs. Depending on the length of
the alkyl side group, R, poly(3-hydroxybutyrate) is a
short-chain-length PHA with R represented by a
methyl group (CH3), while P(3HO) is a medium-
chain-length PHA with R represented by a pentyl
group (C5H11). By blending PHAs of diﬀerent
chain lengths, their properties can be optimised for bio-
medical application and in particular for cartilage
repair, where mechanical and biodegradation proper-
ties are important. P(3HB) has been investigated for
tissue engineering applications that require longer
retention times or high mechanical stability within the
surrounding environment32 and can be modiﬁed with
human procollagen to improve cell adhesion and
proliferation.33
O
O
n
H
CH3
OH
Figure 1. General structure of PHAs; R indicating the alkyl side
group.
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We produced ﬁbrous poly(3-hydroxybutyrate)/
poly(3-hydroxyoctanoate) P(3HB)/P(3HO) scaﬀolds
that: (i) exhibit an ultrastructure similar to the collagen
ﬁbrillar meshwork in native cartilage, (ii) provide a
temporary mechanical support for the chondrocytes
with a similar microenvironment compared to the col-
lagen meshwork in native AC until functional neo-car-
tilage is formed and (iii) are biodegradable and
resorbable to avoid the accumulation of foreign mater-
ial in the body. It is important that the ultrastructure
and the mechanical properties are the keys for a micro-
environment that favours neo-cartilage growth and
without any one of these features, a scaﬀold will not
support cartilage repair. In addition, we demonstrated
that varying the composition of the P(3HB)/P(3HO)
blends allows to optimise the degradation rates. This
is important as the optimum scaﬀold degradation kin-
etics are obtained when the scaﬀold continues to
degrade and lose its mechanical integrity, while the
newly formed neo-cartilage becomes the predominant
mechanical supporting structure to enable successful
tissue regeneration.34,35
Materials and methods
Fabrication of P(3HB)/P(3HO) scaffolds
P(3HB) was isolated from the Gram-positive bacterium
Bacillus cereus SPV and P(3HO) from the Gram-nega-
tive bacterium Pseudomonas mendocina as previously
described by Rai and co-workers.36,37 The molecular
weight, Mw, of P(3HB) was 181,343 g/mol with a poly-
dispersity index of 3.57, whereas the Mw of P(3HO) was
222,270 g/mol with a polydispersity index of 3.73. Solid
P(3HB) and P(3HO) in P(3HB)/P(3HO) ratios of 1:0.25,
1:0.43, 1:0.67, 1:1 were dissolved in chloroform (288306;
Sigma-Aldrich, Gillingham, UK) separately at 30wt.%.
The dissolved P(3HB)/P(3HO) in chloroform were then
mixed together for electrospinning. Electrospinning was
employed using a solution ﬂow rate of 5ml/min, a high
voltage supply of 12kV and a distance between the
spinneret and collector of 20 cm.
Preparation of human AC
Human AC was obtained from the femoral head of
patients undergone total hip replacement surgery at
the Southampton General Hospital, with the approval
of the Southampton General Hospital and South West
Hants Local research Ethnics Committee (LREC 194/
99/1 and 210/01). Cartilage samples were taken from
areas with no apparent signs of damage or disease and
stored in minimum essential medium alpha medium
(MEM a, 11900; Life Technologies, Paisley, UK) on
ice or at 4C until use.
Scanning electron microscopy
Scanning electron microscopy (SEM) was employed
following enzymatic digestion of proteoglycans and
cells of AC samples in phosphate-buﬀered solutions
(PBS, H15–002; PAA Laboratories, Pasching,
Austria) containing 1mg/ml bovine hyaluronidase
(type I, H3506; Sigma-Aldrich) and 1mg/ml trypsin
(Trypsin-EDTA, T4174; Sigma-Aldrich) at 37C for
three days.38 Specimens were then Exed with 4% par-
aformaldehyde (P/0840/53; Fisher Scientiﬁc,
Loughborough, UK) in PBS for 4 h at room tempera-
ture, rinsed with water and dehydrated in graded etha-
nol series. Prior to SEM imaging, all samples were gold
coated with a Hummer 6.2 Sputter System (Anatech,
Union City, CA). SEM (JSM-6500F; JEOL, Tokyo,
Japan) imaging at an accelerating voltage of 10 kV
revealed the meshwork structure and the ﬁbril width
to a depth of 0.25.
Fourier transform infrared spectroscopy
Fourier transform infrared spectroscopy (FTIR) was
employed to identify the presence of chemical func-
tional groups in polymers. A FTIR spectrometer
(Thermo Nicolet 380; Thermo Electron Scientiﬁc
Instrument, Madison, WI) equipped with a Smart
Orbit detector and the OMNIC 32 software was
employed to record FTIR spectra in the range of
4000–400 cm1 at a resolution of 8 cm1. A total of
32 scans were used for signal averaging. The analysis
was repeated three times for each sample.
Indentation-type atomic force microscopy
Stiﬀness was measured by indentation-type atomic
force microscopy (IT-AFM; MFP-3D; Asylum
Research, Santa Barbara, CA) in PBS solution follow-
ing protocols developed by our group.38–40 Spherical
probes were prepared by gluing hard borosilicate
glass spheres (radius, r¼ 5 mm, 02715-AB; SPI
Supplies, West Chester, PA) onto tipless rectangular
cantilever (spring constant, kc 6N/m, type All In
One-TL; BudgetSensors, Soﬁa, Bulgaria). A maximum
deﬂection of 100 nm was employed, corresponding to a
load of 600 nN. Cyclic load–displacement curves were
recorded at 0.5Hz. Each individual data set consisted
of 1024 load–displacement curves in a 32 32 curve
grid, covering a sample area of 30 30 mm, at three
diﬀerent locations. The indentation depths were less
than 10% of the overall sample thickness.41 The stiﬀ-
ness of sample, E, was calculated from equation (1).42
E ¼
ﬃﬃﬃ

p
2
1 v2  Sﬃﬃﬃﬃ
A
p ð1Þ
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where  is the Poisson’s ratio of the sample, S is the
contact stiﬀness with the dimension of force per unit
depth, A is the projected contact area.
Degradation of scaffolds
The degradation of unseeded scaﬀolds was tested in
MEM a medium at 37C. The medium was changed
every two days. After one and four months, the
degraded scaﬀolds were examined by SEM and
IT-AFM. In addition, the molecular weight of the scaf-
folds was analysed by gel permeation chromatography
(1090 HPLC; Hewlett-Packard, Burlington, MA)
equipped with UV-Visible and diﬀerential refractive
index detectors. Dried samples were dissolved in
chloroform at a concentration of 0.10mg/ml and
eluted through PLgel 5 mm Mixed C column (Polymer
Laboratories, Church Stretton, UK) at a ﬂow rate of
1ml/min. A polystyrene standard was used to calibrate
the instrument prior to measurements. The Cirrus GPC
software was employed for analysing data.
In vitro biocompatibility of scaffolds
The focus of this work was to investigate if we can
produce P(3HB)/P(3HO) scaﬀolds with stiﬀness com-
parable to those of native cartilage to support chondro-
genesis. Human articular chondrocytes (HACs) were
isolated from the cartilage specimens following diges-
tion in 1 trypsin-EDTA for 30min, 1mg/ml hyalur-
onidase for 15min and 10mg/ml collagenase B
(11088831001; Roche Diagnostics, West Sussex, UK)
for 15 h.43 The isolated HACs were then expanded in
MEM a supplemented with 10% foetal bovine serum
(FBS, 10270-106; Life Technologies), 100 unit/ml peni-
cillin, 100 mg/ml streptomycin (Penicillin-Streptomycin,
P4333; Sigma-Aldrich) and 100M L-ascorbic acid
2-phosphate sequimagnesium salt hydrate (A8960;
Sigma-Aldrich). The HACs were harvested at conﬂu-
ence by trypsinization (1 trypsin-EDTA) after one
passage. Scaﬀolds were sterilised with absolute ethanol,
rinsed with PBS, and seeded with HACs at a density of
7 105 cells/cm2. The HACs-seeded scaﬀolds were
cultured in chondrogenic induction medium made up
of MEM a supplemented with 10 ng/ml recombinant
human transforming growth factor-b3 (TGF-b3, 100-
36E; Peprotech, London, UK), 100M L-ascorbic
acid 2-phosphate sequimagnesium salt hydrate, 10 nM
dexamethasone (D4902; Sigma-Aldrich), and 1
Insulin-Transferrin-Selenium-G (ITS-G, 41400; Life
Technologies).44 All tissue cultures were incubated
at 37C in humidiﬁed atmosphere with 5% CO2.
Media were exchanged every two days. The constructs
were harvested for live/dead cell staining, histological
and immunohistochemical analysis, and stiﬀness
measurement after three weeks. At least three samples
were tested in each experiment.
Live/dead cell staining. Metabolically active cells were
labelled with 10 mg/ml Cell Tracker Green CMFDA
(5-chloromethylﬂuorescein diacetate, C7025; Life
Technologies), while necrotic cells were labelled with
5 mg/ml Ethidium Homodimer-1 (E1169; Life
Technologies) for an hour. After incubation in tissue
culture medium for 45min, the constructs were ﬁxed
with 4% paraformaldehyde in PBS. The specimens
were embedded in paraﬃn wax and sequential sec-
tions were cut in sections of 7 mm. After de-waxing
with Histoclear (HS200; National Diagnostics,
Leicestershire, UK) and re-hydration through graded
ethanol, cell nuclei were stained with DAPI (40,6-
diamidino-2-phenylindole, dilactate, D3571; Life
Technologies). Fluorescent images were acquired with
Axiovert 200 microscope (Carl Zeiss Microscopy, Jena,
Germany) equipped with Zeiss AxioCam HR colour
camera, AxioCam MR3 monochrome camera and the
Zeiss AxioVision 4.6 software.
Histology and immunohistochemistry. After de-waxing with
Histoclear and re-hydrating through graded ethanol,
cell nuclei were counter-stained with haematoxylin
(H/0010/46; Fisher Scientiﬁc). The proteoglycan con-
tent was stained with 5mg/ml Alcian blue 8GX
(40046-0100; Acros Organics, Geel, Belgium), while
total collagen content was stained with 10mg/ml
Direct Red 80 (365548; Sigma-Aldrich).
The expression of SOX-9, aggrecan, collagen I, II
and X in the neo-cartilage was detected by immunohis-
tochemistry. For anti-SOX-9 and anti-aggrecan antibo-
dies, sections were treated with heat-induced antigen
retrieval in 0.01M citrate buﬀer at 60C for 25min,
followed by quenching endogeneous peroxidase with
3% hydrogen peroxide (H2O2) and blocking with 1%
bovine serum albumin (A3294, Sigma-Aldrich) in PBS.
For anti-collagen I, II and X antibodies, sections were
quenched with 3% H2O2, incubated with 520 mg/ml
bovine hyaluronidase at 37C for 20min and then
blocked with 1% bovine serum albumin. Next, sections
were incubated with the relevant primary antibody at
4C for 18 h. The anti-SOX-9 (AB5535; Millipore,
Billerica, MA) and anti-aggrecan (ab36861; Abcam,
Cambridge, UK) antibodies were used at dilution of
1:150, anti-collagen I antibody (gift from Larry W.
Fisher, National Institutes of Health, Maryland) at
1:1000, anti-collagen II (ab34712; Abcam) and anti-col-
lagen X (234196; Millipore) antibodies at 1:100. This
was followed by incubation with biotinylated second-
ary antibody (B7389; Sigma Aldrich) at a dilution of
1:100 for an hour. Visualisation of the immune complex
involved the avidin-biotin method linked to peroxidase
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(ExtrAvidin Peroxidase, E2886; Sigma-Aldrich) at a
dilution of 1:50 and 3-amino-9-ethylcarbazole (AEC,
132-32-1; Acros Organics, New Jersey). The reaction
products were reddish brown in colour. Negative con-
trols (omission of the primary antibody) were included
in the control sections. Images were captured using an
inverted light microscope (type BX51, Olympus
Corporation, Tokyo, Japan) equipped with a dotSlide
virtual slide system.
Results
Electrospun P(3HB)/P(3HO) fibres
Electrospinning of polymer blends with diﬀerent ratios
of P(3HB)/P(3HO) produced solid ﬁbres with random
orientation. Values for ﬁbre diameters represent aver-
ages over approximately 50 ﬁbres. As shown in
Figure 2(b) to (e), the electrospun ﬁbres exhibit larger
ﬁbre sizes compared to the collagen ﬁbrils in human
AC (Figure 2(a)). The scaﬀold with P(3HB)/P(3HO)
ratio of 1:0.25 exhibited the smallest ﬁbre diameter of
336 98 nm, which is approximately sixfold larger
compared to the diameter of the collagen ﬁbrils. The
scaﬀolds remained stable after immersing in the PBS
solution for up to seven days (results not shown).
FTIR was employed to obtain structural informa-
tion of the individual P(3HB) and P(3HO) polymers
and of the blends. As shown in Figure 3, the most
prominent absorption band in all the FTIR spectra is
visible at 1720 cm1, corresponding to the absorption
band of the ester carbonyl group (C¼O), which is the
main functional group of PHAs. The highly crystalline
P(3HB) shows a lower C¼O absorption band, at
1720 cm1. The blends of P(3HB)/P(3HO) also exhib-
ited C¼O absorption bands at similar wavenumbers,
1721–1722 cm1. The C¼O absorption band was at
1729 cm1 for P(3HO), reﬂecting the more amorphous
nature of P(3HO).45
Stiffness of scaffolds
Using spherical indenters with r¼ 5 mm, the overall
stiﬀness properties of the various structural elements
composing AC and the stiﬀness properties of electro-
spun ﬁbrous meshworks were measured. Figure 4 docu-
ments the stiﬀness of scaﬀolds with four diﬀerent blend
compositions of P(3HB)/P(3HO), which are compared
to the stiﬀness of the superﬁcial zone and deep zone of
native AC.
Superﬁcial AC cartilage stiﬀness was measured on
the original cartilage surface, whereas deep zone cartil-
age was measured after removal of the superﬁcial and
middle zones (2mm). The stiﬀness was higher
for lower content of the soft and elastomeric
P(3HO), with a stiﬀness of 868 540 kPa for the
Increasing amount of P(3HO) increases fibre
thickness
Panel Polymer
54 ± 7
336 ± 98
409 ± 130
583 ± 191
744 ± 462
Articular cartilage
P(3HB)/P(3HO) =
1:0.25
P(3HB)/P(3HO) =
1:0.67
P(3HB)/P(3HO) =
1:1
P(3HB)/P(3HO) =
1:0.43
(nm)
Diameter of fibres
A
B
C
D
E
Figure 2. Comparison of SEM micrographs of the AC collagen meshwork with electrospun P(3HB)/P(3HO) fibres. (a) The collagen
fibril meshwork of human AC after proteoglycan extraction exhibits a pseudo-random meshwork of smooth collagen fibrils with
diameters of 54 7 nm. (b-e) Electrospun fibres with different diameters were fabricated from different ratios of P(3HB)/P(3HO). All
P(3HB)/P(3HO) fibres exhibit smooth surfaces, random orientations of fibres and increasing diameters with an increasing amount of
P(3HO) as shown in the Table. Crosslinkages between some fibres can be observed as indicated by the white arrow heads. Scale bars:
500 nm (a), 2 mm (b–e).
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P(3HB)/P(3HO) 1:0.25 scaﬀold, corresponding to
53% of the stiﬀness of AC measured in the deep
zone (1854 483 kPa) and is 45% higher than the
stiﬀness of AC measured at the superﬁcial zone
(600 150 kPa). The stiﬀness of P(3HB)/P(3HO)
1:0.43 scaﬀold was 654 505 kPa, which is similar to
the stiﬀness of superﬁcial zone AC. Both the stiﬀness of
scaﬀolds with P(3HB)/P(3HO) ratios of 1:0.67 and 1:1
were measured as 274 222 kPa and 346 205 kPa,
respectively.
Degradation of scaffolds
As documented in Figure 5 (a) to (d), changes of ﬁbre
size and morphology were observed after one and four
months (Figure 5 (e) to (h)). During initial degradation
(t¼ 1 month), ﬁbres of all samples appeared swollen. The
average ﬁbre diameter increased by 67% compared to
t¼ 0 for P(3HB)/P(3HO) ratio of 1:0.25, 40% for
1:0.43, 59% for 1:0.67 and 22% for 1:1. After four
months, some of the ﬁbres had been degraded into smal-
ler sized ﬁbres and the individual ﬁbre boundaries were
indistinguishable. Most of the ﬁbre sizes were reduced by
approximately 13–24% compared to their size at t¼ 1
month (Figure 5(i)). Despite the progressive degradation
at four months, the overall ﬁbre structure as well as the
structure of the scaﬀold remained morphologically intact.
As shown in Figure 6, the stiﬀness of scaﬀolds
decreased gradually with increasing degradation.
At one month, the stiﬀness of P(3HB)/P(3HO) 1:0.25
2400
2200
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1600
1400
1200
1000
800
600
400
200
0
1:0.25 1:0.43 1:0.67  1:1
Deep zone human AC
Superficial zone human AC
P(3HB)/P(3HO) ratio
St
iff
ne
ss
 (k
Pa
)
Figure 4. Stiffness measurements of the P(3HB)/P(3HO) scaffolds in comparison to human AC. As indicated by the dashed curve,
the stiffness of scaffolds decreases with the increasing amount of P(3HO). The area in light grey shows the range of stiffness measured
on the superficial zone of human AC, whereas the area in dark grey shows the range of stiffness measured on the deep zone human
AC.
P(3HB) C=O
1720.4
1721.0
1721.3
1721.4
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1729.3
P(3HO)
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Figure 3. The shift in the infrared absorption band of C¼O
indicates the effect of hydrogen bond. FTIR spectra comparing
neat P(3HB), neat P(3HO) and the four different blends of
P(3HB)/P(3HO). The C¼O absorption band at 1720 cm1
slightly shifted to higher wavenumbers with increasing amount of
P(3HO).
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scaﬀold reduced by 34% to 577 475 kPa, which was
still similar to the stiﬀness of superﬁcial zone human
AC. At four months, the stiﬀness further reduced by a
total of 76%, to 206 173 kPa. In comparison, the stiﬀ-
ness of P(3HB)/P(3HO) 1:0.43 scaﬀold reduced by 65%
to 230 178 kPa after one month, and further reduced
by a total of 82%, to 119 53 kPa after four months.
Similarly, the stiﬀness of scaﬀolds with P(3HB)/P(3HO)
ratios of 1:0.67 and 1:1 after four months of degrad-
ation reduced to 186 120 kPa and 108 44 kPa,
respectively.
To further evaluate the scaﬀold degradation, we
measured the molecular weight loss, Mw, of scaﬀolds
with the P(3HB)/P(3HO) ratios of 1:0.25 and 1:0.43.
The P(3HB)/P(3HO) 1:0.25 scaﬀold exhibited a Mw
loss of 19% and 27% after one and four months,
respectively. The Mw loss on P(3HB)/P(3HO) 1:0.43
scaﬀold was slightly lower, with 9% and 12% of Mw
loss after one and four months, respectively. Both the
scaﬀolds showed a higher rate ofMw loss at one month
in comparison to four months.
In vitro biocompatibility of scaffolds
HACs were seeded into the two scaﬀolds with the high-
est stiﬀness, i.e. P(3HB)/P(3HO) ratios of 1:0.25 and
1:0.43. After three weeks of static culturing, the con-
structs transitioned from a loose ﬁbrous meshwork into
a tissue-like material, with a smooth and shiny appear-
ance. To examine the presence of live and dead cells in
the scaﬀolds, a ﬂuorescent double staining protocol
using Cell Tracker Green and Ethidium Homodimer-
1 was employed. Figure 7 shows the representative
ﬂuorescence images of the HACs-seeded scaﬀolds.
The HACs had migrated into the voids and spaces
between ﬁbrils. By counting the amount of live and
dead cells, the cell viability on the scaﬀolds was over
98%, with negligible number of necrotic cells (red
ﬂuorochromes). All P(3HB)/P(3HO) scaﬀolds demon-
strated a similar high degree of cell viability, regardless
of the blend compositions (results not shown).
Figure 8(a) and (a0), reveals the composition
of extracellular matrix by histological staining.
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Figure 5. Comparison of SEM micrographs of the scaffolds after hydrolytic degradation. (a-d) After 1 month of hydrolytic deg-
radation the fibres show larger variations in thickness compared to the original fibres shown in Figure 1. A few fibres became thinner,
whereas the majority of fibres look thicker and some of the fibres were fused together. (e-h) After 4 months of degradation some of
the fibres show a reduced thickness (white arrow heads). The mesh size of the scaffold was reduced because some of the fibres were
fused together. (i) The average diameters of fibres increased after 1 month degradation and decreased after 4 months. Scale bars: 2mm.
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Both constructs showed intense Sirius red staining for
total collagen matrix at the outer rim of the construct,
which was surrounding the Alcian blue staining for
proteoglycan matrix at the core of the construct.
HACs within the constructs were stained with haema-
toxylin in black and were located within lacunae, as
typically seen in the native AC. Since the histology ana-
lysis showed chondrogenesis on the scaﬀolds, immuno-
histochemistry was carried out to visualise the presence
of speciﬁc antigens or proteins in the newly synthesised
extracellular matrix.
As shown in Figure 8(b) and (b0), the master regula-
tor of chondrocyte diﬀerentiation, SOX-9, was immu-
nolocalised in large amounts of chondrocytes. HACs
along the periphery exhibited ﬁbroblast-like cell
morphology, while those penetrated inside the scaﬀolds
showed the typical rounded morphology of chondro-
cytes as in their native environment. While signiﬁcant
1400
1600
1200
1000
800
600
400
200
0
1:0.25
1:0.25
868 ± 540
577 ± 475
206 ± 173
654 ± 505
230 ± 178
119 ± 53
274 ± 222
Stiffness (kPA)
St
iff
ne
ss
 (k
Pa
)
236 ± 217
186 ± 120
346 ± 205
151 ± 90
107 ± 44
1:0.43
1:0.43
1:0.67
1:0.67
P(3HB)/P(3HO) ratio
P(3HB)/P(3HO) = P(3HB)/P(3HO) = P(3HB)/P(3HO) = P(3HB)/P(3HO) =Time
0
1
4
(month)
1:1
1:1
Figure 6. Decrease in the stiffness of scaffolds after hydrolytic degradation. The red curve shows the original stiffness of the scaffolds
made from the different P(3HB)/P(3HO) ratios. The green curve shows the decrease of stiffness after 1 month of degradation,
whereas the blue curve shows a further reduction in stiffness after 4 months of degradation.
Figure 7. Viability test of HACs-seeded on the P(3HB)/P(3HO) 1:0.25 scaffold. (a) Cell nuclei are shown in blue (DAPI staining),
whereas the cell cytoplasm is shown in green (Cell Tracker Green staining). (b) A necrotic cell is shown in red as indicated by the white
arrow head (Ethidium Homdimer-1 staining). Scale bars: 50 mm.
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amount of the cartilage-speciﬁc proteoglycan, the aggre-
can, was detected on the P(3HB)/P(3HO) 1:0.25 scaﬀold
(Figure 8(c)), there was lack of formation of aggrecan on
the P(3HB)/P(3HO) 1:0.43 scaﬀold (Figure 8(c0)). The
positive staining of aggrecan on the P(3HB)/P(3HO)
1:0.25 scaﬀold was mainly detected along with the
SOX-9 expressed HACs. We also measured the expres-
sion levels of collagen types I, II and X to further deter-
mine the quality of our constructs. As shown in Figure
8(d) and (d0), type II collagen was detected at high levels
on both constructs, in most chondrocytes and in the
extracellular regions. The expression of the ﬁbrous type
I collagen on P(3HB)/P(3HO) 1:0.25 scaﬀold, shown in
Figure 8(e), wasweaker compared to the P(3HB)/P(3HO)
1:0.43 scaﬀold shown in Figure 8(e0). Figure 8(f) and (f0),
documents the formation of type X collagen in both con-
structs, particularly along the periphery, therefore indi-
cating the presence of hypertrophic chondrocytes.
The distribution of proteoglycan and collagen con-
tent in the repair tissue was signiﬁcantly diﬀerent com-
pared to native AC. As shown in Figure 9(a), the
histology of human AC shows a uniform distribution
of collagen content (red) at the surface region and the
proteoglycan content (blue) at the inner region.
Corresponding to the uniformity of the content, we
measured a unimodal stiﬀness distribution as shown
in Figure 9(b). In contrast, and as shown in
Figure 9(c), the construct that was cultured for three
weeks revealed discrete regions of proteoglycan and
total collagen content. This construct exhibited stiﬀness
that varied with the locations being measured, with an
average stiﬀness of 9 3 kPa at the soft region
versus 1061 600 kPa at the stiﬀ region (Figure 9(d)).
The variations in the stiﬀness distribution are in agree-
ment with the histological analysis. In addition, the thin
sheets of electrospun ﬁbres rumpled during cell cultur-
ing and were shown as layers in the histology of the
construct (Figure 9(c)).
Discussion
The chondrocytes in native AC are embedded into the
3D collagen meshwork, which provides a highly specia-
lised ﬁbril surface morphology and chemistry as well as
a micromechanical environment that allows chondro-
genesis.46 Those chemical and physical properties need
to be equally implemented into man-made scaﬀolds to
grow functional cartilage. As has been shown, ﬁbrous
scaﬀolds support higher chondrocyte growth rates and
improve tissue formation compared to sponge-like 47 or
porous solution cast ﬁlms.48 Here, we employed elec-
trospinning to produce ﬁbrous meshworks from vari-
ous blends of P(3HB)/P(3HO) as ‘guiding’ structures to
direct cartilage repair. P(3HB) is a member of the PHA
family of natural biopolymers exhibiting a linear
3-carbon atom polyester with a methyl (CH3) side
group. The side groups on the polymer chain point
away from the centre, which allows the chain to form
helical structures that exhibit the minimal steric hin-
drance. Hence, the chains can easily pack together to
form crystals, making the polymer brittle and stiﬀ. To
increase its ﬂexibility, the P(3HB) polymer can be
blended with PHAs of longer pendant chain lengths.
For example, P(3HO) is a medium-chain-length PHA,
also a linear 3-carbon atom polyester but with a pentyl
(C5H11) side group. The long alkyl side groups inhibit
the close packing of the polymer in a regular 3D fash-
ion to form crystalline array,49 thereby decreasing its
crystallinity and giving P(3HO) its amorphous and ﬂex-
ible properties.
As shown in Figure 2, ﬁbre diameters increased
with increasing P(3HO) in the blends and can be
explained by the reduced crystallinity of
P(3HO). The superimposition of the stiﬀ and rigid
P(3HB) with the soft and elastomeric P(3HO) in dif-
ferent volume fractions allows to ﬁne tune the mech-
anical properties of the ﬁbres forming the scaﬀolds.50
Figure 8. Histology and immunohistochemistry showing cartilage formation on two scaffolds (a-f) P(3HB)/P(3HO) 1:0.25 scaffold
and (a’-f’) P(3HB)/P(3HO) 1:0.43 scaffold. (a, a’) Histology of proteoglycan matrix is shown in blue and the total collagen matrix in red.
Cell nuclei are stained with haematoxylin in black. (b-f, b’-f ’) Immunohistochemistry of (b, b’) SOX-9, (c, c’) aggrecan, (d, d’) type II
collagen, (e, e’) type I collagen and (f, f ’) type X collagen. Positive reaction was detected with the chromogenic AEC substrate, which
imparts a brownish colour to the cells. Scale bars: 50 mm.
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Figure 4 shows the decrease of stiﬀness and increase
of the overall ﬂexibility of scaﬀolds when increasing
the amount of the amorphous P(3HO).36,51 The
diameter of the electrospun ﬁbres depends on the vis-
cosity of polymer solution, the ejection ﬂow rate,
the applied voltage and the distance between the
spinneret and the collector. The current electrospin-
ning set-up allows to produce ﬁbres with diameters
as small as approximately 300 nm when using
P(3HB)/P(3HO) ratio of 1:0.25. In comparison to
these large ﬁbres, chondrocytes in native AC anchor
tightly on collagen ﬁbrils with diameters that are typ-
ically between 10 to 300 nm.46,52 Smaller diam-
eter ﬁbres similar to the collagen ﬁbrils in AC can
be produced by either reducing the viscosity of the
polymer solution or by decreasing the ejection ﬂow
rate. However, electrospinning of smaller diam-
eter ﬁbres drastically increases the time to produce
scaﬀolds.
Stabilisation of the ﬁbrous scaﬀolds even without
crosslinking agents is provided by the molecular struc-
ture of PHAs, which has a carbonyl bond (C¼O) ori-
ented perpendicular to the ﬁbre axis.53 The ﬁbrous
structure is further stabilised by a hydrogen bond
that forms between the C¼O and CH3 groups
(C–HO¼C).54,55 At this stage, we decided not to use
further (chemical) crosslinking, because the P(3HB)/
P(3HO) scaﬀolds were mechanically stable in PBS
and could be handled by forceps. As shown in
Figure 3, we measured the vibrational frequency of
the C¼O bonds of both P(3HB) and P(3HO) by
using FTIR. The eﬀect of hydrogen bond on the vibra-
tional frequency of C¼O bonds can be seen as a shift
in wavenumbers from 1750–1730 cm1 towards
lower wavenumbers of 1729 cm1 for P(3HO) and
1720 cm1 for P(3HB).56 The larger shift for P(3HB)
can be explained by the stronger hydrogen bond typic-
ally found in PHAs, which weakens the C¼O bond
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Figure 9. Images and measurements of stiffness of human AC and HACs-seeded P(3HB)/P(3HO) 1:0.25 scaffold cultured for
3 weeks. (a) Histology of human AC showing the proteoglycan matrix in blue and total collagen matrix in red (black arrow heads
indicate the surface side for stiffness measurement). (b) Stiffness of the superficial zone of human AC shows a unimodal distribution.
(c) Histology shows the localised distributions of proteoglycan (blue) and collagen (red) matrix of the construct. (d) The stiffness of
the 3-week-cultured construct revealed soft and stiff regions. Scale bars: 200 mm.
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and resulting in a lower C¼O absorption wavenumber.
Lower C¼O absorption wavenumbers are typically
measured from a more crystalline structure.45 As the
crystallinity of the polymer decreases with increasing
P(3HO), the structure of P(3HO) is less ordered and
the strength of hydrogen bonding is reduced, resulting
in a smaller frequency shift. These variations in the
chemical structures based on altered hydrogen bonds
allow to systematically develop a toolbox with diﬀerent
P(3HB)/P(3HO) blends to produce scaﬀolds with dif-
ferent functional properties. A higher content of
P(3HB) may be more suitable for producing scaﬀolds
for stiﬀer tissues, such as bone, whereas a higher
P(3HO) content provides more ﬂexible scaﬀolds for
cardiovascular stents, pericardial patches and heart
valves.
The degradation rate of scaﬀolds also controls the
space generated in the extracellular matrix to allow cell
proliferation and deposition of newly synthesised extra-
cellular matrix. The degraded scaﬀold structure and
stiﬀness in Figures 5 and 6 show the eﬀects of hydro-
lytic degradation on the P(3HB)/P(3HO) scaﬀolds. We
estimate that the degradation process occurs between
one and a few years.57 It has been proved that the
hydrolytic degradation of PHB proceeds via random
chain scission, regardless of the microstructure. 58
With increasing amounts of P(3HO), the degradation
rates are slower, because the presence of long alkyl side
group sterically hinders the attack of water molecules.37
The degradation of PHAs would produce exclusively
monomers of PHAs, i.e. 3-hydroxybutyric acids,
which naturally occur in various human tissues,32,59
under enzymatic or biological conditions. 3-hydroxybu-
tyric acid monomers are synthesised in the liver from
where they are released into the blood stream and
absorbed by extrahepatic tissues, such as heart and
skeletal muscles, for the generation and utilisation of
metabolic energy. Although hydrolysis might not often
proceed regioselectively ‘cutting’ only the last mono-
meric unit of PHAs, the short-chain products (oligo-
mers) that are formed from hydrolytic degradation
are also soluble in water or PBS, and their biocompati-
bility has been reported.60–61 In comparison, the cur-
rently used synthetic absorbable polymers, such as
PGA and PLA, degrading into 2-hydroxy acids with
a pKa of 3.83 (glycolic acid) and pKa of 3.08 (lactic
acid) and that may cause inﬂammation, 3-hydroxybu-
tyric acid are signiﬁcantly less acidic with a lower pKa
of 4.70.62–64 It has also been reported that (R)-3-hydro-
xybutyric acid can increase the cardiac eﬃciency of
heart failure patients,65 or act as an alternative energy
source to glucose for diabetic patients.66
As shown in Figure 7, the high cell viability in three-
week-cultured constructs provided further evidence of
the low cytotoxicity of the degradation products
released during cell culturing. However, due to the add-
itional enzymatic reactions from cells and tissues, the
in vivo degradation rates of the P(3HB)/P(3HO) scaf-
folds may be faster compared to their in vitro degrad-
ation rates.57 The degradation of P(3HB)
gastrointestinal patch was accelerated by threefold
due to pancreatin enzyme.32 However, due to the lack
of blood supply in cartilage, the eﬀect of enzymatic
action on P(3HB) in cartilage is expected to be lower.
The degradation time for P(3HB)/P(3HO) may vary
from one to a few years, but the optimal degradation
time constant for the ingrowth of repair cartilage needs
to be determined experimentally.
Functional neo-cartilage with biochemical compos-
ition, architecture, and mechanical properties that clo-
sely mimics native AC may provide the highest clinical
success rates for regaining joint function.67,68 To evalu-
ate the potential of employing PHA scaﬀolds for car-
tilage repair, their ability to maintain high cell viability
and cell function is of key importance for chondrocytes
to build the complex protein structures and to repair
cartilage.27,67,69 However, the large majority of previ-
ous work was based on synthetic scaﬀolds that do not
degrade and, therefore, do not hamper a proper devel-
opment of the large proteoglycan and collagen mol-
ecules for forming the 3D tissue matrix. In non-
degradable scaﬀolds, these large molecules are
restricted in the lacunae or in the pericellular region
as the deposition of large molecules requires more
space in the scaﬀold structure.70 As documented by
histological analysis of our constructs shown in
Figure 8(a) and (a0), the degraded P(3HB)/P(3HO) scaf-
folds provide suﬃcient space for the newly secreted
extracellular matrix. The depletion of oxygen from
high levels at the periphery towards hypoxic environ-
ment at the centre of the constructs highly inﬂuences
the quality of the matrix. Although chondrocytes are
known to be well adapted to the hypoxic environment
within native cartilage tissue, both aerobic and anaer-
obic metabolic pathways exist in cartilage constructs.71
A threshold oxygen level of 8% has been estimated for
HAC in a 3D pellet culture model, above which col-
lagenous matrix production is favoured, while lower
levels of oxygen favour proteoglycan deposition.72 We
believe that the use of degrading scaﬀolds that give
space for the development of new matrix proteins is
important for producing competent cartilage.
The expression levels of SOX-9 serve as a marker for
chondrogenic induction, which includes the production
of type II collagen and aggrecan. In a series of key
experiments, transfected cells with a vector containing
SOX-9 resulted in chondrocytic cells, whereas knocking
out of this gene resulted in inhibition of cartilage for-
mation.73 As shown in Figure 8(b) and (b0), large
amounts of HACs are of SOX-9 positive, particularly
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among the ﬁne and straight ﬁbres, which indicates that
the HACs respond to the morphological features of
their surrounding matrix (and maybe also to the
growth factor cocktail containing TGF-b). As docu-
mented in Figure 8 (d) and (d0), the high expression
levels of type II collagen suggest the formation of hya-
line-like cartilage. However, the expression levels of
aggrecan in both constructs were diﬀerent. Aggrecan
was formed alongside the SOX-9 expressing cells in
the P(3HB)/P(3HO) 1:0.25 construct (Figure 8(c)), as
SOX-9 promotes the gene expression of aggrecan.
Conversely, as shown in Figure 8(c0), the chondrocytes
in P(3HB)/P(3HO) 1:0.43 construct may have de-diﬀer-
entiated, causing the synthesis of small non-cartilagi-
nous proteoglycans and low expression levels of
aggrecan.74 This is attributed to the diﬀerences in the
structure and stiﬀness microenvironment of the con-
structs. Through cell surface receptors, a cell possesses
the ability for tactile sensation. A myriad of physical
and chemical (growth factors) signals from the sur-
rounding matrix is transmitted through the various
cell surface receptors, which then induces intracellular
signalling pathways that regulate gene expression and
direct the cells’ phenotype. As a result, the complex cell
fate processes modulate the formation, function and
regeneration of tissue.75 The ﬂow of information
between cells and their extracellular matrix is reﬂected
in the changes of cell morphology and motility rate in
response to changes of their surrounding stiﬀness.76,77
The de-diﬀerentiation of chondrocytes is followed by
an altered protein expression, including a reduced syn-
thesis of aggrecan and type II collagen. The construct
with P(3HB)/P(3HO) ratio of 1:0.25 exhibited smaller
ﬁbre sizes and higher stiﬀness compared to that with a
ratio of 1:0.43, hence, is more closely mimicking the
native AC. The lower expression levels of type I colla-
gen in the P(3HB)/P(3HO) 1:0.25 scaﬀold compared to
that on the 1:0.43 scaﬀold further support the hypoth-
esis that the microenvironment modulates cell fate, pro-
tein expression and tissue formation.
The high expression levels of type II collagen in both
constructs suggest the development of functional cartil-
age. However, Figure 8 (f) and (f0), shows relatively
high expression levels of type X collagen in the con-
structs, pointing to a transition from the chondrocytic
phenotype towards the terminal phase of hypertrophic
diﬀerentiation. One possible explanation for the chon-
drocyte de-diﬀerentiation is that the expression of
SOX-9 in the chondrocytes was not continuing
throughout the entire culturing period. In addition,
the chondrogenic stimuli that employ TGF-b, dexa-
methasone and ITS-G can induce chondrogenic diﬀer-
entiation but also promote the up-regulation of type X
collagen.78 The potential of matrix calciﬁcation induced
by type X collagen may assist in the integration of the
newly formed repair tissue with the subchondral bone,
or be an indication of cartilage remodelling, which may
alter the accumulation of proteoglycans and modifying
the diﬀusion properties of the matrix.79 To maintain the
normal expression levels of SOX-9 during culturing
period remains a challenge in the tissue engineering of
cartilage.80
The diﬀerences in local stiﬀness properties reﬂect the
local variations in the composition of neo-cartilage com-
pared to the native cartilage.81 As shown by the uni-
modal stiﬀness distribution on native AC in
Figure 9(b), a spherical indenter with a radius of 5mm
was unable to detect the variations in the structural com-
ponents on the surface of native AC, thereby, indicating
that the local structural variations exhibit smaller dimen-
sions.39 In comparison, stiﬀness measurements on the
constructs, as shown in Figure 9(d), demonstrate that
the variations in the structural components of neo-carti-
lage were large enough to be detected by the spherical
indenter. Discrete soft and stiﬀ regions on the surface
were measured, and, therefore, giving an estimate for the
heterogeneity of the construct. Considering that cells
have a stiﬀness of three orders of magnitude smaller
than the extracellular matrix, and proteoglycans exhibit
soft gel-like properties, the low stiﬀness region of the
construct is attributed to the cell- and proteoglycan-
rich content. Meanwhile, the high stiﬀness region is
attributed to the collagen-rich content or the scaﬀold
structure.40 IT-AFM measurements on the three-week-
old construct indicate some promising hyaline-like car-
tilage formation. However, further in vivo experiments
will allow to investigate the performance of these
scaﬀolds in the speciﬁc microenvironment of living
organisms.
Conclusion
Unlike the self-healing abilities in some other species,
the human body needs a supporting structure with a
close-to-native microenvironment that aids as a tem-
plate to direct the growth of cartilage. Any deviation
of physical or chemical properties from what a cell
experiences in its native microenvironment may cause
de-diﬀerentiation of chondrocytes and may lead to
altered protein expressions. By following nature’s
design principles, we electrospun P(3HB)/P(3HO)
blends to mimic the collagen meshwork in AC. The
ultrastructure and mechanical properties of the scaf-
folds in combination are vitally important in providing
a microenvironment that favours the diﬀerentiation of
chondrocytes and neo-cartilage growth. Based on our
results, we believe that the P(3HB)/P(3HO) scaﬀolds
can be developed into a clinical repair product to heal
cartilage defects and avoid the development of second-
ary osteoarthritis. In addition, the biodegradable
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blends of P(3HB)/P(3HO) may allow to establish a
toolbox with tailored scaﬀolds for the repair of a var-
iety of other tissues such as bone, pericardial patches,
or biodegradable cardiovascular stents.
Acknowledgements
The authors would like to thank Professor Robert J.K. Wood
for supporting this research and Professor Richard Oreﬀo for
providing his research facilities for the biocompatibility tests.
We acknowledge the support from the Scholarships
Committee of the University of Westminster for the support
to Dr Pooja Basnett.
Declaration of conflicting interests
The author(s) declared no potential conﬂicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) received no ﬁnancial support for the research,
authorship, and/or publication of this article.
References
1. Hunter W. On the structure and diseases of articulating
cartilage. Philos Trans R Soc Lond B Biol Sci 1743; 42:
514–521.
2. Pridie KH. A method of resurfacing osteoarthritic knee
joints. J Bone Joint Surg Br 1959; 41: 618–619.
3. Johnson LL. Arthroscopic abrasion arthroplasty histor-
ical and pathologic perspective: Present status.
Arthroscopy 1986; 2: 54–69.
4. Steadman JR, Rodkey WG, Singleton SB, et al.
Microfracture technique for full-thickness chondral
defects: technique and clinical results. Oper Tech Orthop
1997; 7: 300–304.
5. Mithoefer K, Mcadams T, Williams RJ, et al. Clinical
efficacy of the microfracture technique for articular car-
tilage repair in the knee: An evidence-based systematic
analysis. Am J Sports Med 2009; 37: 2053–2063.
6. Sharma B, Fermanian S, Gibson M, et al. Human cartil-
age repair with a photoreactive adhesive-hydrogel com-
posite. Sci Transl Med 2013; 5: 167ra166.
7. BrittbergM, Lindahl A,Nilsson A, et al. Treatment of deep
cartilage defects in the knee with autologous chondrocyte
transplantation. N Engl J Med 199; 331: 889-895.
8. Briggs TW, Mahroof S, David LA, et al. Histological
evaluation of chondral defects after autologous chondro-
cyte implantation of the knee. J Bone Joint Surg Br 2003;
85: 1077–1083.
9. Horas U, Pelinkovic D, Herr G, et al. Autologous chon-
drocyte implantation and osteochondral cylinder trans-
plantation in cartilage repair of the knee joint.
A prospective, comparative trial. J Bone Joint Surg Am
2003; 85: 185–192.
10. Knutsen G, Engebretsen L, Ludvigsen TC, et al.
Autologous chondrocyte implantation compared with
microfracture in the knee. A randomized trial. J Bone
Joint Surg Am 2004; 86: 455–464.
11. Schneider U and Andereya S. First results of a prospect-
ive randomized clinical trial on traditional chondrocyte
transplantation vs cares-technology. Z Orthop Ihre
Grenzgeb 2003; 141: 496–497.
12. Behrens P, Bitter T, Kurz B, et al. Matrix-associated
autologous chondrocyte transplantation/implantation
(mact/maci) – 5-year follow-up. Knee 2006; 13: 194–202.
13. Marcacci M, Berruto M, Brocchetta D, et al.
Articular cartilage engineering with Hyalograft C: 3-year
clinical results. Clin Orthop Relat Res 2005; 435: 96–105.
14. Stanish WD, Mccormack R, Forriol F, et al. Novel scaf-
fold-based bst-cargel treatment results in superior cartil-
age repair compared with microfracture in a randomized
controlled trial. J Bone Joint Surg Am 2013; 95:
1640–1650.
15. Regentis Biomaterials Ltd. Gelrinc. A novel, acellular
treatment for cartiage lesions on the femoral condyle.
White paper, Or Akiva, Israel, 2014.
16. Bryant SJ and Anseth KS. Hydrogel properties influence
ecm production by chondrocytes photoencapsulated in
poly(ethylene glycol) hydrogels. J Biomed Mater Res
2002; 59: 63–72.
17. Mikos AG, Sarakinos G, Leite SM, et al. Laminated
three-dimensional biodegradable foams for use in tissue
engineering. Biomaterials 1993; 14: 323–330.
18. Freed LE, Vunjak-Novakovic G, Biron RJ, et al.
Biodegradable polymer scaffolds for tissue engineering.
Nat Biotechnol 1994; 12: 689–693.
19. Li WJ, Cooper JA, Mauck RL, et al. Fabrication and
characterization of six electrospun poly(alpha-hydroxy
ester)-based fibrous scaffolds for tissue engineering appli-
cations. Acta Biomater 2006; 2: 377–385.
20. Ossendorf C, Kaps C, Kreuz PC, et al. Treatment of
posttraumatic and focal osteoarthritic cartilage defects
of the knee with autologous polymer-based three-dimen-
sional chondrocyte grafts: 2-year clinical results. Arthritis
Res Ther 2007; 9: R41.
21. Carmont MR, Carey-Smith R, Saithna A, et al. Delayed
incorporation of a trufit plug: Perseverance is recom-
mended. Arthroscopy 2009; 25: 810–814.
22. Lee SJ, Han SI and Shim IK. Fibrous 3-dimensional
scaffold via electrospinning for tissue regeneration and
method for preparing the same. Patent 12/064,801, USA,
2008.
23. Sung HJ, Meredith C, Johnson C, et al. The effect of
scaffold degradation rate on three-dimensional cell
growth and angiogenesis. Biomaterials 2004; 25:
5735–5742.
24. Bergsma JE, De Bruijn WC, Rozema FR, et al. Late
degradation tissue response to poly(l-lactide) bone
plates and screws. Biomaterials 1995; 16: 25–31.
25. Athanasiou KA, Niederauer GG and Agrawal CM.
Sterilization, toxicity, biocompatibility and clinical appli-
cations of polylactic acid/polyglycolic acid copolymers.
Biomaterials 1996; 17: 93–102.
26. Gunatillake PA and Adhikari R. Biodegradable synthetic
polymers for tissue engineering. Eur Cell Mater 2003; 5:
1–16.
Ching et al. 13
 at University of Southampton on March 25, 2016jba.sagepub.comDownloaded from 
27. Huey DJ, Hu JC and Athanasiou KA. Unlike bone, car-
tilage regeneration remains elusive. Science 2012; 338:
917–921.
28. Reilly GC and Engler AJ. Intrinsic extracellular matrix
properties regulate stem cell differentiation. J Biomech
2010; 43: 55–62.
29. Weaver VM, Petersen OW, Wang F, et al. Reversion of
the malignant phenotype of human breast cells in three-
dimensional culture and in vivo by integrin blocking anti-
bodies. J Cell Biol 1997; 137: 231–245.
30. Bissell MJ and Hines WC. Why don’t we get more
cancer? A proposed role of the microenvironment in
restraining cancer progression. Nat Med 2011; 17:
320–329.
31. Chaudhuri O, Koshy ST, Branco Da, et al. Extracellular
matrix stiffness and composition jointly regulate the
induction of malignant phenotypes in mammary epithe-
lium. Nat Mater 2014; 13: 970–978.
32. Chen GQ and Wu Q. The application of polyhydroxyalk-
anoates as tissue engineering materials. Biomaterials
2005; 26: 6565–6578.
33. Kawalec M, Sitkowska A, Sobota M, et al. Human pro-
collagen type I surface-modified PHB-based non-woven
textile scaffolds for cell growth: Preparation and short-
term biological tests. Biomed Mater 2014; 9: 065005.
34. Hutmacher DW. Scaffolds in tissue engineering bone and
cartilage. Biomaterials 2000; 21: 2529–2543.
35. Eglin D, Mortisen D and Alini M. Degradation of syn-
thetic polymeric scaffolds for bone and cartilage tissue
repairs. Soft Matter 2009; 5: 938–947.
36. Rai R, Yunos DM, Boccaccini AR, et al. Poly-3-
hydroxyoctanoate P(3HO), a medium chain length poly-
hydroxyalkanoate homopolymer from pseudomonas
mendocina. Biomacromolecules 2011; 12: 2126–2136.
37. Basnett P, Ching KY, Stolz M, et al. Novel poly(3-hydro-
xyoctanoate)/poly(3-hydroxybutyrate) blends for medical
applications. React Funct Polym 2013; 73: 1340–1348.
38. Stolz M, Raiteri R, Daniels A, et al. Dynamic elastic
modulus of porcine articular cartilage determined at
two different levels of tissue organization by indenta-
tion-type atomic force microscopy. Biophys J 2004; 86:
3269–3283.
39. Stolz M, Gottardi R, Raiteri R, et al. Early detection
of aging cartilage and osteoarthritis in mice and patient
samples using atomic force microscopy. Nat Nanotechnol
2009; 4: 186–192.
40. Loparic M, Wirz D, Daniels AU, et al. Micro- and nano-
mechanical analysis of articular cartilage by indentation-
type atomic force microscopy: Validation with a
gel-microfiber composite. Biophys J 2010; 98: 2731–2740.
41. Bueckle H. The science of hardness testing and its
research applications. In: Westbrook JH, Conrad H
(eds) The science of hardness testing and its research appli-
cations. Ohio: American Society for Metals, 1973.
42. Oliver WC and Pharr GM. An improved technique for
determining hardness and elastic modulus using load and
displacement sensing indentation experiments. J Mater
Res 1992; 7: 1564–1583.
43. De Andres MC, Imagawa K, Hashimoto K, et al.
Suppressors of cytokine signalling (socs) are reduced in
osteoarthritis. Biochem Biophys Res Commun 2011; 407:
54–59.
44. Malpeli M, Randazzo N, Cancedda R, et al. Serum-free
growth medium sustains commitment of human articular
chondrocyte through maintenance of SOX9 expression.
Tissue Eng 2004; 10: 145–155.
45. Kansiz M, Dominguez-Vidal A, Mcnaughton D, et al.
Fourier-transform infrared (FTIR) spectroscopy for
monitoring and determining the degree of crystallisation
of polyhydroxyalkanoates (PHAs). Anal Bioanal Chem
2007; 388: 1207–1213.
46. Mankin HJ, Mow VC and Buckwalter JA. Articular car-
tilage structure, composition, and function.
In: Buckwalter JA, Einhorn TA, Simon SR (eds)
Orthopaedic basic science: Biology and biomechanics of
the musculoskeletal system. Illinois: American Academy
of Orthopaedic Surgeons, 2000.
47. Freed LE, Marquis JC, Nohria A, et al. Neocartilage
formation in vitro and in vivo using cells cultured on
synthetic biodegradable polymers. J Biomed Mater Res
1993; 27: 11–23.
48. Lee I, Kwon O, Meng W, et al. Nanofabrication of
microbial polyester by electrospinning promotes cell
attachment. Macromol Res 2004; 12: 374–378.
49. Sanchez RJ, Schripsema J, Da Silva LF, et al. Medium-
chain-length polyhydroxyalkanoic acids (PHA(mcl)) pro-
duced by pseudomonas putida ipt 046 from renewable
sources. Eur Polym J 2003; 39: 1385–1394.
50. Dufresne A and Vincendon M. Poly(3-hydroxybutyrate)
and poly(3-hydroxyoctanoate) blends: morphology and
mechanical behavior. Macromolecules 2000; 33:
2998–3008.
51. Asrar J, Valentin HE, Berger PA, et al. Biosynthesis and
properties of poly(3-hydroxybutyrate-co-3-hydroxyhex-
anoate) polymers. Biomacromolecules 2002; 3: 1006–1012.
52. Mow VC, Gu WY and Chen FH. Structure and func-
tion of articular cartilage and meniscus. In: Mow VC,
Huiskes R (eds) Basic orthopaedic biomechanics and
mechano-biology. Pennsylvania: Lippincott Williams &
Wilkins, 2005.
53. Chan KHK, Wong SY, Li X, et al. Effect of molecular
orientation on mechanical property of single electrospun
fiber of poly[(r)-3-hydroxybutyrate-co-(r)-3-hydroxyvale-
rate]. J Phys Chem B 2009; 113: 13179–13185.
54. Sato H, Murakami R, Padermshoke A, et al. Infrared
spectroscopy studies of CH. . .O hydrogen bondings and
thermal behavior of biodegradable poly(hydroxyalkano-
ate). Macromolecules 2004; 37: 7203–7213.
55. Hu Y, Zhang JM, Sato H, et al. C-H. . .O¼C hydrogen
bonding and isothermal crystallization kinetics of poly(3-
hydroxybutyrate) investigated by near-infrared spectros-
copy. Macromolecules 2006; 39: 3841–3847.
56. Stuart B. Infrared spectroscopy: fundamentals and appli-
cations. New Jersey: John Wiley & Sons, 2004.
57. Marois Y, Zhang Z, Vert M, et al. In vivo biocompati-
bility and degradation studies of polyhydroxyoctanoate
in the rat: a new sealant for the polyester arterial pros-
thesis. Tissue Eng 1999; 5: 369–386.
58. Kurcok P, Kowalczuk M, Adamus G, et al.
Degradability of PHB. Correlation with chemical
14 Journal of Biomaterials Applications 0(0)
 at University of Southampton on March 25, 2016jba.sagepub.comDownloaded from 
microstructure. J Macromol Sci Pure Appl Chem 1995;
A32: 875–880.
59. Scandola M, Focarete ML, Adamus G, et al. Polymer
blends of natural poly(3-hydroxybutyrate-co-3-hydroxy-
valerate) and a synthetic atactic poly(3-hydroxybutyrate).
Characterization and biodegradation studies. Macromo-
lecules 1997; 30: 2568–2574.
60. Gogolewski S, Jovanovic M, Perren SM, et al. Tissue
response and in vivo degradation of selected polyhydrox-
yacids: polylactides (PLA), poly(3-hydroxybulyrate)
(PHB), and poly(3-hydroxybulyrate-co-3-hydroxyvalerate)
(PHB/VA). J Biomed Mater Res 1993; 27: 1135–1148.
61. Piddubnyak V, Kurcok P, Matuszowicz A, et al. Oligo-3-
hydroxybutyrates as potential carriers for drug delivery.
Biomaterials 2004; 25: 5271–5279.
62. Taylor MS, Daniels AU, Andriano KP, et al. Six bioab-
sorbable polymers: In vitro acute toxicity of accumulated
degradation products. J Appl Biomater 1994; 5: 151–157.
63. Weng YX, Wang XL and Wang YZ. Biodegradation
behavior of phas with different chemical structures
under controlled composting conditions. Polym Test
2011; 30: 372–380.
64. Chen Q, Liang S and Thouas GA. Elastomeric biomater-
ials for tissue engineering. Prog Polym Sci 2013; 38:
584–671.
65. Sato K, Kashiwaya Y, Keon CA, et al. Insulin, ketone
bodies, and mitochondrial energy transduction. FASEB J
1995; 9: 651–658.
66. Gumbiner B, Wendel JA and Mcdermott MP. Effects of
diet composition and ketosis on glycemia during very-
low-energy-diet therapy in obese patients with non-insu-
lin-dependent diabetes mellitus. Am J Clin Nutr 1996; 63:
110–115.
67. Lebaron RG and Athanasiou KA. Ex vivo synthesis of
articular cartilage. Biomaterials 2000; 21: 2575–2587.
68. Athanasiou KA, Darling EM and Hu JC. Articular car-
tilage tissue engineering. California: Morgan & Claypool
Publishers, 2009.
69. Stevens MM and George JH. Exploring and engineer-
ing the cell surface interface. Science 2005; 310:
1135–1138.
70. Bryant SJ, Bender RJ, Durand KL, et al. Encapsulating
chondrocytes in degrading peg hydrogels with high
modulus: engineering gel structural changes to facilitate
cartilaginous tissue production. Biotechnol Bioeng 2004;
86: 747–755.
71. Malda J, Martens DE, Tramper J, et al. Cartilage tissue
engineering: controversy in the effect of oxygen. Crit Rev
Biotechnol 2003; 23: 175–194.
72. Li S, Oreffo ROC, Sengers BG, et al. The effect of
oxygen tension on human articular chondrocyte
matrix synthesis: integration of experimental and compu-
tational approaches. Biotechnol Bioeng 2014; 111:
1876–1885.
73. Bi W, Huang W, Whitworth DJ, et al. Haploinsufficiency
of sox9 results in defective cartilage primordia and pre-
mature skeletal mineralization. Proc Natl Acad Sci USA
2001; 98: 6698–6703.
74. Vonwil D. Chondro progenitor cell response to specifically
modified substrate interfaces. PhD Thesis, University of
Basel, Switzerland, 2010.
75. Lutolf MP and Hubbell JA. Synthetic biomaterials as
instructive extracellular microenvironments for morpho-
genesis in tissue engineering. Nat Biotechnol 2005; 23:
47–55.
76. Lo CM, Wang HB, Dembo M, et al. Cell movement is
guided by the rigidity of the substrate. Biophys J 2000; 79:
144–152.
77. Discher DE, Janmey P and Wang YL. Tissue cells feel
and respond to the stiffness of their substrate. Science
2005; 310: 1139–1143.
78. Johnstone B, Alini M, Cucchiarini M, et al. Tissue engin-
eering for articular cartilage repair – the state of the art.
Eur Cell Mater 2013; 25: 248–267.
79. Richardson JB, Caterson B, Evans EH, et al. Repair of
human articular cartilage after implantation of autolo-
gous chondrocytes. J Bone Joint Surg Br 1999; 81:
1064–1068.
80. Hiramatsu K, Sasagawa S, Outani H, et al. Generation of
hyaline cartilaginous tissue from mouse adult dermal
fibroblast culture by defined factors. J Clin Invest 2011;
121: 640–657.
81. Klein TJ, Chaudhry M, Bae WC, et al. Depth-dependent
biomechanical and biochemical properties of fetal, new-
born, and tissue-engineered articular cartilage. J Biomech
2007; 40: 182–190.
Ching et al. 15
 at University of Southampton on March 25, 2016jba.sagepub.comDownloaded from 
